Download and read our latest publications

NAMLG Newsletter – February 2024

Access the newsletter here.

Early response evaluation by single cell signaling profiling in acute myeloid leukemia

Nature Communication 14, 115 (2023)

Access article here

Research article: Ex vivo venetoclax sensitivity testing predicts treatment response in acute myeloid leukemia

Haematologica Early view Dec 15, 2022

Access article here

Research article: Implementing a Functional Precision Medicine Tumor Board for Acute Myeloid Leukemia

Cancer Discov (2022) 12 (2): 388–401.

Access article here

The LD-VenEX phase II clinical trial: AN ex vivo flow cytometry based-drug screening of AML patient samples

Workshop and Symposium 2022, 5– 7 . september 2022, Helsinki, Finland

See poster

Why a Nordic AML Group?

Recognizeable systems in Nordic countries, similar treatment traditions, one working market.

Unmet need to improve AML therapy through research and clinical trials.

Sign up for our newsletter

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.

Contact us

Cookies

Nettstedet er levert av Mediebruket.